" class="no-js "lang="en-US"> Chadi Nabhan - Medtech Alert
Wednesday, August 13, 2025
Chadi Nabhan

Chadi Nabhan

About Chadi Nabhan

Dr. Chadi Nabhan joined Caris Life Sciences® in April of 2020 as Chairman of Precision Oncology Alliance™. As chairman, Dr. Nabhan leads a collaborative network of leading cancer centers that demonstrates a commitment to precision medicine.

Prior to joining Caris Dr. Nabhan was Chief Medical Officer of Aptitude Health, a global provider of oncology insights. He was also Chief Medical Officer at Cardinal Health Specialty Solutions where he led clinical programs, real-world evidence, HEOR, regulatory, publications and strategic initiatives for key stakeholders. Previously, Dr. Nabhan was an Associate Professor of Medicine, and Medical Director of the Clinical Cancer Center at the University of Chicago where he oversaw the clinical operations of cancer clinics and supervised all aspects of cancer care delivery. He is currently an Adjunct Professor in the Department of Clinical Pharmacy at the University of South Carolina.

Dr. Nabhan maintains active medical licenses in five states, has over 300 peer-reviewed articles and abstracts, and has hosted his own award-winning healthcare podcast named “Healthcare Unfiltered” since October 2020.

Related Story

Caris Precision Oncology Alliance Announces the Addition of Columbia University Irving Medical Center to Its Collaborative Network of Precision Medicine Experts

November 19 2021

Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]

Caris’ Precision Oncology Alliance Welcomes The Georgia Cancer Center at Augusta University

November 12 2021

Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]

Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts

October 29 2021

Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced […]